Roxas, Eduardo G.

HRN: 09-98-25  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/05/2026
CEFUROXIME 1.5GM (VIAL)
05/05/2026
05/05/2026
IV
1.5g
Now
Incarcerated Inguinal Hernia Right
Checking Initial Appropriateness 
05/05/2026
CEFUROXIME 750MG (VIAL)
05/05/2026
05/12/2026
IV
750mg
Q8h
Incarcerated Inguinal Hernia Right
Rejected 
05/05/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/05/2026
05/12/2026
IV
500mg
Q8h
Indirect Inguinal Hernia Right
Checking Initial Appropriateness 
05/08/2026
CEFUROXIME 500MG (TAB)
05/08/2026
05/15/2026
PO
500mg
Q8h
Repair Of Indirect Inguinal Hernia Right Using Mesh Enterolysis
Checking Initial Appropriateness 
05/08/2026
METRONIDAZOLE 500MG (TAB)
05/08/2026
05/15/2026
PO
500mg
Q8h
Repair Of Indirect Inguinal Hernia Right Using Mesh Enterolysis
Checking Initial Appropriateness 
05/08/2026
CEFUROXIME 500MG (TAB)
05/08/2026
05/15/2026
ORAL
500mg
BID
S/P Mesh Hernioplasty
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: